14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $14.59 $16.67 Thursday, 25th Apr 2024 CPRX stock ended at $14.68. This is 2.91% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.91% from a day low at $14.59 to a day high of $15.01.
90 days $13.12 $17.50
52 weeks $11.09 $17.77

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
Aug 15, 2023 $14.83 $15.08 $14.77 $14.98 1 130 284
Aug 14, 2023 $14.80 $14.99 $14.64 $14.86 1 268 176
Aug 11, 2023 $15.08 $15.59 $14.84 $14.88 1 435 780
Aug 10, 2023 $15.03 $15.21 $14.01 $15.02 2 361 361
Aug 09, 2023 $14.27 $14.30 $13.98 $14.12 1 325 043
Aug 08, 2023 $13.97 $14.47 $13.97 $14.33 1 690 277
Aug 07, 2023 $14.00 $14.28 $13.93 $13.98 1 839 659
Aug 04, 2023 $13.61 $14.03 $13.46 $13.92 1 158 353
Aug 03, 2023 $13.48 $13.74 $13.44 $13.55 857 494
Aug 02, 2023 $13.63 $13.83 $13.47 $13.47 1 029 018
Aug 01, 2023 $13.80 $13.91 $13.61 $13.75 714 393
Jul 31, 2023 $14.01 $14.08 $13.75 $13.83 936 671
Jul 28, 2023 $13.51 $14.06 $13.49 $13.97 1 524 117
Jul 27, 2023 $13.41 $13.59 $13.24 $13.34 968 394
Jul 26, 2023 $13.41 $13.41 $13.22 $13.31 897 402
Jul 25, 2023 $13.25 $13.77 $13.23 $13.41 1 085 450
Jul 24, 2023 $13.63 $13.65 $13.40 $13.54 1 064 945
Jul 21, 2023 $13.73 $13.84 $13.62 $13.66 971 585
Jul 20, 2023 $13.57 $13.73 $13.38 $13.68 1 124 561
Jul 19, 2023 $13.95 $14.12 $13.40 $13.57 1 804 941
Jul 18, 2023 $13.52 $13.91 $13.28 $13.89 1 695 514
Jul 17, 2023 $12.90 $13.52 $12.88 $13.47 1 725 905
Jul 14, 2023 $12.69 $12.97 $12.50 $12.86 1 010 323
Jul 13, 2023 $12.85 $12.88 $12.61 $12.62 896 250
Jul 12, 2023 $12.89 $12.90 $12.57 $12.80 1 135 943
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT